Hepatocellular Carcinoma in the Setting of HBV Infection: Risk Assessment, Screening, and Surveillance

Download this PDF guide outlining key information on HCC risk assessment, screening, and surveillance in the setting of Hepatitis B infection.
Robert S. Brown, Jr., MD, MPH
Format: Adobe Acrobat (.pdf)
File Size: 88 KB
Released: February 22, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
Gilead Sciences, Inc.

Related Content

Clinical Care Options (CCO) expert analysis by Dr Stefan Zeuzem on new viral hepatitis data from AASLD 2022

Stefan Zeuzem, MD Released: December 8, 2022

Expert analysis by Dr Nancy Reau on new viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)

Nancy Reau, MD Released: December 8, 2022

Nancy Reau, MD Released: December 8, 2022

Dr Nancy Reau: practice-changing viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)

Nancy Reau, MD Released: December 6, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings